Vascular and renal translational research group

Betriu À; Farràs C; Abajo, M; Martinez-Alonso, M; Arroyo, D; Barbe, F; Buti, M; Lecube, A; Portero, M; Purroy, F; Torres, G; Valdivielso, JM; Fernandez, E

Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

Nefrologia 36 389-396. 01/07/2016.

[doi:10.1016/j.nefro.2016.02.008]

Borràs Sans M; Chacón Camacho A; Cerdá Vilaplana C; Usón Nuño A; Fernandez, E

Incremental peritoneal dialysis: Clinical outcomes and residual kidney function preservation

Nefrologia 36 299-303. 01/05/2016.

[doi:10.1016/j.nefro.2016.01.006]

Rivera Gorrín M; Cornago Delgado I; Betriu Bars À; Lanuza Luengo M; Ceballos Guerrero M; Paraíso Cuevas V; Ibeas López J; Roca Tey R; Quirós Ganga PL

Creation of the Working Group on Diagnostic and Interventional Nephrology of the Spanish Society of Nephrology

Nefrologia 36 325-326. 01/05/2016.

[doi:10.1016/j.nefro.2015.11.004]

Valdivielso, J; Martinez-Alonso, M; Betriu, A; Gracia, M; Arroyo, D; Abajo, M; Salgueira, M; Gorriz, JL; Fernandez, E

THE NUMBER OF ARTERIAL TERRITORIES WITH ATHEROMA PLAQUE PREDICTS THE TIME FREE FROM CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE. ANALYSIS OF THE NEFRONA STUDY AFTER 36 MONTHS OF FOLLOW-UP

NEPHROLOGY DIALYSIS TRANSPLANTATION 31 1429-1429. 01/05/2016.

Rubinat E; Marsal JR; Vidal T; Cebrian C; Falguera M; Vilanova MB; Betriu À; Fernández E; Franch J; Mauricio D

Subclinical Carotid Atherosclerosis in Asymptomatic Subjects With Type 2 Diabetes Mellitus

Journal Of Cardiovascular Nursing 31 1-7. 01/03/2016.

[doi:10.1097/JCN.0000000000000236]

Fernandez-Laso, V; Sastre, C; Valdivielso, JM; Betriu, A; Fernandez, E; Egido, J; Martin-Ventura, JL; Blanco-Colio, LM

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD

Clinical Journal Of The American Society Of Nephrology 11 413-422. 01/03/2016.

[doi:10.2215/CJN.07900715]

Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM

Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD

Clinical Journal Of The American Society Of Nephrology 11 287-296. 01/02/2016.

[doi:10.2215/CJN.01240215]

Doria, M; Rosado, V; Roxana Pacheco, Linda; Hernandez, M; Betriu, A; Valls, J; Franch-Nadal, J; Fernandez, E; Mauricio, D

Prevalence of Diabetic Foot Disease in Patients with Diabetes Mellitus under Renal Replacement Therapy in Lleida, Spain

BioMed Research International 2016 7217586-7217586. 01/01/2016.

[doi:10.1155/2016/7217586]

Jover, R; Bozic, M; Guzman, C; Sanchez-Campos, S; Garcia-Monzon, C; Valdivielso, JM

VITAMIN D RECEPTOR IS UP-REGULATED IN NAFLD HEPATOCYTES AND IS REQUIRED FOR HIGH FAT DIET-INDUCED STEATOSIS IN APOE(-/-) MICE LIVER

JOURNAL OF HEPATOLOGY 64 682-682. 01/01/2016.

[doi:10.1016/S0168-8278(16)01294-0]

Bover, J; Ureña-Torres P; Lloret, MJ; Ruiz-Garcia, C; DaSilva, I; Diaz-Encarnacion, MM; Mercado, C; Mateu, S; Fernandez, E; Ballarin, J

Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification

Expert Opinion On Pharmacotherapy 17 1247-1258. 01/01/2016.

[doi:10.1080/14656566.2016.1182155]

Marco Mayayo MP; Martinez Alonso M; Valdivielso Revilla JM; Fernandez-Giraldez, E

A New Gender-Specific Formula to Estimate 24-Hour Urine Protein from Protein to Creatinine Ratio

Nephron 133 232-238. 01/01/2016.

[doi:10.1159/000447604]

Bover, J; Ureña-Torres P; Lloret, MJ; Ruiz, C; DaSilva, I; Diaz-Encarnacion, MM; Mercado, C; Mateu, S; Fernandez, E; Ballarin, J

Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification

Expert Opinion On Pharmacotherapy 17 1363-1373. 01/01/2016.

[doi:10.1080/14656566.2016.1182985]